Table 2.
Entry | Ligand | Hormonal activity (U2OS Cells)a | Growth inhibition | ||||
---|---|---|---|---|---|---|---|
ERα | ERβ | IC50 after 96h [μM] | |||||
| |||||||
IA b [%] | CD c [%] | IA b [%] | CD c [%] | MCF-7 | MDA-MB-231 | ||
1. | 1 d | 49 | 93 | 50 | 96 | 7.3 | 5.4 |
2. | 2 d | 79 | 95 | 104 | 92 | 9.0 | 9.1 |
3. | 3 d | 81 | 93 | 89 | 91 | 5.1 | 5.6 |
4. | 4 d | 22 | 86 | 58 | 86 | 5.5 | 4.9 |
5. | 5 d | 22 | 78 | 32 | 77 | 1.8 | 1.2 |
6. | 6 d | 33 | 88 | 89 | 85 | <0.63 | >20 |
7, | 6 e | −7 | 80 | 55 | 90 | <0.63 | >20 |
8. | 7 f | 90 | 93 | 95 | 92 | 6.5 | 5.6 |
9. | DES g | 105 | 103 | 111 | 90 | 5.9 | 4.3 |
Concentration of 1–7 was 10μM.
Intrinsic activity (IA).
Cell density (CD).
Pure Z-Z isomer.
Pure E-Z isomer.
The bivalent DES ligand 7 was evaluated based on 60% E-E isomer.
The concentration was 10nM.